Medis - Version QFR - Quantitative Flow Ratio Software
Quantitative Flow Ratio (QFR) from Medis Medical Imaging offers a novel, safe1, non-invasive approach to physiology designed to enhance procedural efficiency2, drive economic value* and improve the patient’s procedural experience**. Medis QFR is being distributed by ACIST Medical in North America only.
- Supported by extensive clinical evidence and a large number of trials and publications3
- Excellent correlation and accuracy compared to FFR4
- Strong diagnostic performance compared to iFR5
- Performed in more than 12,000 patients and 16,000 vessels3
- Peer-reviewed in more than 85 publications3
- A 3D model is reconstructed from two angiography images to calculate QFR.
- You are then presented with physiological and anatomicalinformation on one screen.
Improve patient experience** and delivery efficient workflow.
Improved patient experience**
- No adenosine needed
- No invasive pressure wire required
- Shorter procedure time
Safe1, accurate4 & streamlined workflow
- Applicable pre, during, and post PCI
- Supports predictable treatment with Residual QFR
- Reduces physiological assessment time by 29%2
- No purchase of capital equipment required
- No adenosine or pressure wire used
- Efficient workflow both online and off
- Arturo Cesaro, et al; Fractional assessment of coronary stenosis; An overview of available techniques. Is quantitative flow ratio a step to the future? 2018 July 11.
- Westra J, Andersen BK, et al; Diagnostic performance of in-procedure angiography-derived Quantitative Flow Reserve compared to pressure-derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study. J Am Heart Assoc 2018.
- Data on file. 35-100018.
- Choi et al. Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease. International Journal of Cardiology. Sept 2020.
- Emori H, Kubo T, Ket al; Quantitative flow ratio and instantaneous wave-free ratio for the assessment of the functional severity of intermediate coronary artery stenosis. Coronary Artery Disease 2018.
* Reduced side effect profile when compared to FFR with adenosine induced hyperemia
** Cost savings based on the reduced cost of QFR compared to conventional FFR and the respective cost of administration of hyperemic agent (adenosine) and additional invasive proce dural resources